Ineye Pharma

Healthy eyes for a lifetime

OWNER

Marcos Mariz (See Profile)


Sector

Medical Device

Stage

Prototyping, preclinical

Country

Portugal


InEye® is a patented technology of an ocular insert for prolonged (7 to 200 days) release of bioactive molecules.

Proven excellent biocompatibility and tolerance in rabbits (no adverse effects).

Already raised approximately half million euros, from government science funds and 5 awards, all non-dilutive.

We want to have a Proof-of-Concept in humans for InEye® as a medical device for patients with dry eye in 2025.

Status

Approved

IP Type

Patent

Time

14 years

Countries

Australia
Austria
Belgium
Canada
Denmark
Finland
France
Germany
Italy
Japan
Netherlands
Russia
Spain
Switzerland
USA
United Kingdom

Coverage

It protects the polymer composition, design and structure to be used as an ophthalmic insert and the immobilization techniques used for various bioactive molecules.

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 21st of March 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar